NOVEL IMMUNOTHERAPEUTIC APPROACHES FOR THE TREATMENT OF ALLERGIC DISEASES
- 1 August 2000
- journal article
- Published by Elsevier in Immunology and Allergy Clinics of North America
- Vol. 20 (3) , 625-642
- https://doi.org/10.1016/s0889-8561(05)70170-3
Abstract
No abstract availableThis publication has 76 references indexed in Scilit:
- IFN-τ inhibits IgE production in a murine model of allergy and in an IgE-producing human myeloma cell lineJournal of Allergy and Clinical Immunology, 1999
- IMMUNOLOGIC BASIS OF ANTIGEN-INDUCED AIRWAY HYPERRESPONSIVENESSAnnual Review of Immunology, 1999
- Crossreactivity and T‐cell epitope specificity of Bet v 1‐specific T cells suggest the involvement of multiple isoallergens in sensitization to birch pollenClinical and Experimental Allergy, 1997
- INDUCTION OF TH1 AND TH2 CD4+T CELL RESPONSES:The Alternative ApproachesAnnual Review of Immunology, 1997
- Altered Peptide Ligand–Induced Partial T Cell Activation: Molecular Mechanisms and Role in T Cell BiologyAnnual Review of Immunology, 1996
- IL-12 PossibilitiesScience, 1995
- Characterization of Complex Formation by Humanized Anti-IgE Monoclonal Antibody and Monoclonal Human IgEBiochemistry, 1995
- Potential therapeutic recombinant proteins comprised of peptides containing recombined T cell epitopesMolecular Immunology, 1994
- Regulation of the human immune response to ragweed pollen by immunotherapy. A controlled trial comparing the effect of immunosuppressive peptic fragments of short ragweed with standard treatmentClinical and Experimental Allergy, 1991
- Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1Nature, 1985